Rating History for Cartesian Therapeutics (RNAC) by Cantor Fitzgerald

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/9/2026 Kristen Kluska Upgrade Overweight
(Neutral)
16.00
(N/A)
6.85
(9.63)
40.58% Details